Dynacef Suspension 5 ml Powder for oral suspension

Dynacef Suspension 5 ml Powder for oral suspension

S4
PDF Leaflet Revision Date: 06 December 2024

API: Cefpodoxime | Company: Pharma Dynamics

Clinical Summary

Quick overview from the medicine insert

Indication

Short-term treatment of respiratory tract infections in children.

Dosage (summary)

Children: 8 mg/kg/day; 5 mL (40 mg) every 12 hours for 10-15 kg; 10 mL (80 mg) every 12 hours for u226515 kg.

Special Populations

  • Renal impairment
  • Hepatic impairment

Pregnancy & Breastfeeding

Not applicable.

Key Drug Interactions

  • Probenecid
  • Anticoagulants
  • Antacids

Contraindications

  • Hypersensitivity to beta-lactams
  • Phenylketonuria
  • Children <1 year

Common side effects

  • Diarrhoea
  • Nausea
  • Headache
  • Dizziness

Counselling Points

  • Take with food for better absorption
  • Shake well before use
  • Report severe diarrhea immediately

Serious warnings

  • Serious hypersensitivity reactions
  • Clostridium difficile-associated disease
Important Disclaimer

The Dynacef Suspension 5 ml Powder for oral suspension professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites